Shareholders of Chile-based firm CFR Pharmaceuticals gave a nod on Friday for a sweetened takeover offer for South African drug maker Adcock Ingram in a bid to woo the top shareholder of the South African firm.
CFR Pharmaceuticals
Cape Town, South Africa-based investment firm Foord Asset Management has lifted its stake in Johannesburg-based drug maker Adcock Ingram to 15%, according to a regulatory filing on Friday.
South Africa-based asset manager Oasis Group Holdings has sold off its 2.2% stake in pharmaceutical firm Adcock Ingram to an undisclosed buyer, according to a spokesman.
South Africa's industrial conglomerate has joined forces with unlisted drug firm Community Investment Holdings (CIH) to buy a stake in Adcock Ingram in a move that could derail Chilean company CFR Pharmaceutical's takeover bid, said a Business Day Live report.
Chile-based drug firm CFR Pharmaceuticals promised a 25.1% stake for its black shareholders should the acquisition of local pharmaceutical company Adcock Ingram be approved, in line with South Africa's black economic empowerment (BEE) codes.
Subscribe to VCpost newsletter
Most Popular
- Trump Justifies Earning Millions from Foreign Governments During Presidency
- Supreme Court Hints at Granting Trump Criminal Immunity, Jan 6 Trial Delay Looms
- SSI Payment: Double Social Security Benefits in May? Here’s When You Will Receive Yours!
- Elon Musk Says US Companies Not Spending At Least $10 Billion on AI Like Tesla 'Cannot Compete'
- Businessman Who Shot His Wife to Death Thinking She Was an Intruder Gets Only 12 Years in Prison
- Tyson Foods Found Dumping Million Pounds of Toxic Pollutants into US Waterways
- Trans Woman Beaten to Death Outside Florida Ballet Studio
- Jewelry Maker Cartier Agrees to Let Mexican Man Keep $13,000 Worth of Earrings Only Bought for $13 After Website Mistake